United States CD40 Ligand Market Report 2018

Name: United States CD40 Ligand Market Report 2018
Brand: QYResearch
SKU: U752BF4E877QEN
Price: 3800 USD
Availability: InStock

March 2018 | 102 pages | ID: U752BF4E877QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States CD40 Ligand market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of CD40 Ligand in these regions, from 2013 to 2025 (forecast).

United States CD40 Ligand market competition by top manufacturers/players, with CD40 Ligand sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Biogen, Inc.
Bristol-Myers Squibb Company
eTheRNA Immunotherapies NV
ImmuNext, Inc.
Juno Therapeutics Inc.
MedImmune, LLC
Targovax AS
XL-protein GmbH

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

ISF-35
LOAd-700
MEDI-4920
MegaCD40L
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hepatitis B
Bladder Cancer
Liver Cancer
Ovarian Cancer
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

United States CD40 Ligand Market Report 2018

1 CD40 LIGAND OVERVIEW

1.1 Product Overview and Scope of CD40 Ligand
1.2 Classification of CD40 Ligand by Product Category
  1.2.1 United States CD40 Ligand Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States CD40 Ligand Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 ISF-35
  1.2.4 LOAd-700
  1.2.5 MEDI-4920
  1.2.6 MegaCD40L
  1.2.7 Others
1.3 United States CD40 Ligand Market by Application/End Users
  1.3.1 United States CD40 Ligand Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hepatitis B
  1.3.3 Bladder Cancer
  1.3.4 Liver Cancer
  1.3.5 Ovarian Cancer
  1.3.6 Others
1.4 United States CD40 Ligand Market by Region
  1.4.1 United States CD40 Ligand Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West CD40 Ligand Status and Prospect (2013-2025)
  1.4.3 Southwest CD40 Ligand Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic CD40 Ligand Status and Prospect (2013-2025)
  1.4.5 New England CD40 Ligand Status and Prospect (2013-2025)
  1.4.6 The South CD40 Ligand Status and Prospect (2013-2025)
  1.4.7 The Midwest CD40 Ligand Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of CD40 Ligand (2013-2025)
  1.5.1 United States CD40 Ligand Sales and Growth Rate (2013-2025)
  1.5.2 United States CD40 Ligand Revenue and Growth Rate (2013-2025)

2 UNITED STATES CD40 LIGAND MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States CD40 Ligand Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States CD40 Ligand Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States CD40 Ligand Average Price by Players/Suppliers (2013-2018)
2.4 United States CD40 Ligand Market Competitive Situation and Trends
  2.4.1 United States CD40 Ligand Market Concentration Rate
  2.4.2 United States CD40 Ligand Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers CD40 Ligand Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CD40 LIGAND SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States CD40 Ligand Sales and Market Share by Region (2013-2018)
3.2 United States CD40 Ligand Revenue and Market Share by Region (2013-2018)
3.3 United States CD40 Ligand Price by Region (2013-2018)

4 UNITED STATES CD40 LIGAND SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States CD40 Ligand Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States CD40 Ligand Revenue and Market Share by Type (2013-2018)
4.3 United States CD40 Ligand Price by Type (2013-2018)
4.4 United States CD40 Ligand Sales Growth Rate by Type (2013-2018)

5 UNITED STATES CD40 LIGAND SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States CD40 Ligand Sales and Market Share by Application (2013-2018)
5.2 United States CD40 Ligand Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES CD40 LIGAND PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Biogen, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 CD40 Ligand Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Biogen, Inc. CD40 Ligand Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Company
  6.2.2 CD40 Ligand Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Company CD40 Ligand Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 eTheRNA Immunotherapies NV
  6.3.2 CD40 Ligand Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 eTheRNA Immunotherapies NV CD40 Ligand Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 ImmuNext, Inc.
  6.4.2 CD40 Ligand Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 ImmuNext, Inc. CD40 Ligand Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Juno Therapeutics Inc.
  6.5.2 CD40 Ligand Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Juno Therapeutics Inc. CD40 Ligand Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 MedImmune, LLC
  6.6.2 CD40 Ligand Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 MedImmune, LLC CD40 Ligand Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Targovax AS
  6.7.2 CD40 Ligand Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Targovax AS CD40 Ligand Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 XL-protein GmbH
  6.8.2 CD40 Ligand Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 XL-protein GmbH CD40 Ligand Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview

7 CD40 LIGAND MANUFACTURING COST ANALYSIS

7.1 CD40 Ligand Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of CD40 Ligand

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 CD40 Ligand Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of CD40 Ligand Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CD40 LIGAND MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States CD40 Ligand Sales Volume, Revenue Forecast (2018-2025)
11.2 United States CD40 Ligand Sales Volume Forecast by Type (2018-2025)
11.3 United States CD40 Ligand Sales Volume Forecast by Application (2018-2025)
11.4 United States CD40 Ligand Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of CD40 Ligand
Figure United States CD40 Ligand Market Size (K Pcs) by Type (2013-2025)
Figure United States CD40 Ligand Sales Volume Market Share by Type (Product Category) in 2017
Figure ISF-35 Product Picture
Figure LOAd-700 Product Picture
Figure MEDI-4920 Product Picture
Figure MegaCD40L Product Picture
Figure Others Product Picture
Figure United States CD40 Ligand Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of CD40 Ligand by Application in 2017
Figure Hepatitis B Examples
Table Key Downstream Customer in Hepatitis B
Figure Bladder Cancer Examples
Table Key Downstream Customer in Bladder Cancer
Figure Liver Cancer Examples
Table Key Downstream Customer in Liver Cancer
Figure Ovarian Cancer Examples
Table Key Downstream Customer in Ovarian Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States CD40 Ligand Market Size (Million USD) by Region (2013-2025)
Figure The West CD40 Ligand Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest CD40 Ligand Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic CD40 Ligand Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England CD40 Ligand Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US CD40 Ligand Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest CD40 Ligand Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States CD40 Ligand Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States CD40 Ligand Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States CD40 Ligand Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States CD40 Ligand Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States CD40 Ligand Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States CD40 Ligand Sales Share by Players/Suppliers
Figure 2017 United States CD40 Ligand Sales Share by Players/Suppliers
Figure United States CD40 Ligand Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States CD40 Ligand Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States CD40 Ligand Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States CD40 Ligand Revenue Share by Players/Suppliers
Figure 2017 United States CD40 Ligand Revenue Share by Players/Suppliers
Table United States Market CD40 Ligand Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market CD40 Ligand Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States CD40 Ligand Market Share of Top 3 Players/Suppliers
Figure United States CD40 Ligand Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers CD40 Ligand Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers CD40 Ligand Product Category
Table United States CD40 Ligand Sales (K Pcs) by Region (2013-2018)
Table United States CD40 Ligand Sales Share by Region (2013-2018)
Figure United States CD40 Ligand Sales Share by Region (2013-2018)
Figure United States CD40 Ligand Sales Market Share by Region in 2017
Table United States CD40 Ligand Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States CD40 Ligand Revenue Share by Region (2013-2018)
Figure United States CD40 Ligand Revenue Market Share by Region (2013-2018)
Figure United States CD40 Ligand Revenue Market Share by Region in 2017
Table United States CD40 Ligand Price (USD/Pcs) by Region (2013-2018)
Table United States CD40 Ligand Sales (K Pcs) by Type (2013-2018)
Table United States CD40 Ligand Sales Share by Type (2013-2018)
Figure United States CD40 Ligand Sales Share by Type (2013-2018)
Figure United States CD40 Ligand Sales Market Share by Type in 2017
Table United States CD40 Ligand Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States CD40 Ligand Revenue Share by Type (2013-2018)
Figure Revenue Market Share of CD40 Ligand by Type (2013-2018)
Figure Revenue Market Share of CD40 Ligand by Type in 2017
Table United States CD40 Ligand Price (USD/Pcs) by Types (2013-2018)
Figure United States CD40 Ligand Sales Growth Rate by Type (2013-2018)
Table United States CD40 Ligand Sales (K Pcs) by Application (2013-2018)
Table United States CD40 Ligand Sales Market Share by Application (2013-2018)
Figure United States CD40 Ligand Sales Market Share by Application (2013-2018)
Figure United States CD40 Ligand Sales Market Share by Application in 2017
Table United States CD40 Ligand Sales Growth Rate by Application (2013-2018)
Figure United States CD40 Ligand Sales Growth Rate by Application (2013-2018)
Table Biogen, Inc. Basic Information List
Table Biogen, Inc. CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Biogen, Inc. CD40 Ligand Sales Growth Rate (2013-2018)
Figure Biogen, Inc. CD40 Ligand Sales Market Share in United States (2013-2018)
Figure Biogen, Inc. CD40 Ligand Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company CD40 Ligand Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company CD40 Ligand Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Company CD40 Ligand Revenue Market Share in United States (2013-2018)
Table eTheRNA Immunotherapies NV Basic Information List
Table eTheRNA Immunotherapies NV CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure eTheRNA Immunotherapies NV CD40 Ligand Sales Growth Rate (2013-2018)
Figure eTheRNA Immunotherapies NV CD40 Ligand Sales Market Share in United States (2013-2018)
Figure eTheRNA Immunotherapies NV CD40 Ligand Revenue Market Share in United States (2013-2018)
Table ImmuNext, Inc. Basic Information List
Table ImmuNext, Inc. CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure ImmuNext, Inc. CD40 Ligand Sales Growth Rate (2013-2018)
Figure ImmuNext, Inc. CD40 Ligand Sales Market Share in United States (2013-2018)
Figure ImmuNext, Inc. CD40 Ligand Revenue Market Share in United States (2013-2018)
Table Juno Therapeutics Inc. Basic Information List
Table Juno Therapeutics Inc. CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Juno Therapeutics Inc. CD40 Ligand Sales Growth Rate (2013-2018)
Figure Juno Therapeutics Inc. CD40 Ligand Sales Market Share in United States (2013-2018)
Figure Juno Therapeutics Inc. CD40 Ligand Revenue Market Share in United States (2013-2018)
Table MedImmune, LLC Basic Information List
Table MedImmune, LLC CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure MedImmune, LLC CD40 Ligand Sales Growth Rate (2013-2018)
Figure MedImmune, LLC CD40 Ligand Sales Market Share in United States (2013-2018)
Figure MedImmune, LLC CD40 Ligand Revenue Market Share in United States (2013-2018)
Table Targovax AS Basic Information List
Table Targovax AS CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Targovax AS CD40 Ligand Sales Growth Rate (2013-2018)
Figure Targovax AS CD40 Ligand Sales Market Share in United States (2013-2018)
Figure Targovax AS CD40 Ligand Revenue Market Share in United States (2013-2018)
Table XL-protein GmbH Basic Information List
Table XL-protein GmbH CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure XL-protein GmbH CD40 Ligand Sales Growth Rate (2013-2018)
Figure XL-protein GmbH CD40 Ligand Sales Market Share in United States (2013-2018)
Figure XL-protein GmbH CD40 Ligand Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of CD40 Ligand
Figure Manufacturing Process Analysis of CD40 Ligand
Figure CD40 Ligand Industrial Chain Analysis
Table Raw Materials Sources of CD40 Ligand Major Players/Suppliers in 2017
Table Major Buyers of CD40 Ligand
Table Distributors/Traders List
Figure United States CD40 Ligand Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States CD40 Ligand Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States CD40 Ligand Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States CD40 Ligand Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States CD40 Ligand Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States CD40 Ligand Sales Volume (K Pcs) Forecast by Type in 2025
Table United States CD40 Ligand Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States CD40 Ligand Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States CD40 Ligand Sales Volume (K Pcs) Forecast by Application in 2025
Table United States CD40 Ligand Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States CD40 Ligand Sales Volume Share Forecast by Region (2018-2025)
Figure United States CD40 Ligand Sales Volume Share Forecast by Region (2018-2025)
Figure United States CD40 Ligand Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States CD40 Ligand Market Report 2018

More Publications

Need Help?

Ask a Question

Market Reports